Breaking News

Advarra Offers Complimentary Transfer of IRB Oversight

Provides access to eRegulatory management software and a dedicated resource for guidance on emerging issues impacted by COVID-19

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Advarra is providing free resources to support and enable the clinical research during the coronavirus disease (COVID-19) pandemic. This includes complimentary transfer of IRB oversight, access to a new version of Forte eRegulatory management software, eReg Lite, and a dedicated “Ask Advarra” resource for guidance on emerging issues impacted by COVID-19. “Advarra has been reviewing more COVID-19 research since the beginning with priority reviews and reduced fees, but we want...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters